Anti-coronavirus efforts in Beijing

Anti-coronavirus efforts in Beijing

A person wearing protective gear walks in Beijing on Dec. 13, 2022, amid the spread of coronavirus infections.

  • Product Code
  • ILEA001076623
  • Registered date
  • 2022/12/13 00:00:00
  • Credit
  • Kyodo / Kyodo News Images
  • Media source
  • 2022 Kyodo News
  • Media size
  • 3968 × 2645 pixel
  • Resolution
  • 240 dpi
  • Deployment size
  • 767.98(KB)*
  • Special instruction

*File size when opened in Photoshop, etc.

Similar Images & Videos
Anti-Alzheimer's drug lecanemab

Anti-Alzheimer's drug lecanemab

Haruo Naito, CEO of Japanese pharmaceutical company Eisai Co., attends a press conference in Tokyo on Dec. 13, 2023, as the company's anti-Alzheimer's drug lecanemab is set to be launched on Dec. 20, following a health ministry advisory body's approval of its coverage by the Japanese public insurance scheme.
Beijing amid COVID resurgence

Beijing amid COVID resurgence

Photo taken June 13, 2023, shows the entrance of a Beijing hospital for outpatient services, as China sees a resurgence in the number of COVID-19 cases.
Beijing amid COVID resurgence

Beijing amid COVID resurgence

Photo taken June 13, 2023, shows the entrance of a Beijing hospital for outpatient services, as China sees a resurgence in the number of COVID-19 cases.

Japan remains largely masked up on 1st day of eased COVID rules

Japan's easing of coronavirus guidelines on mask-wearing had little apparent effect on Monday, with many people still opting to stick with the habit that has been entrenched for the past three years amid the pandemic. Passengers step into a shinkansen bullet train at JR Tokyo Station on March 13, 2023, while wearing face masks despite Japan on the same day easing its COVID-19 guidelines on mask-wearing.
China's anti-COVID drug Azvudine

China's anti-COVID drug Azvudine

Photo taken on Jan. 10, 2023, shows an assembly line for oral anti-COVID drug Azvudine at a factory of China Resources Double-Crane Pharmaceutical Co. in Beijing. The Chinese government unveiled the factory to the media amid rampant coronavirus infections in the country.
China's anti-COVID drug Azvudine

China's anti-COVID drug Azvudine

Photo taken on Jan. 10, 2023, shows an assembly line for oral anti-COVID drug Azvudine at a factory of China Resources Double-Crane Pharmaceutical Co. in Beijing. The Chinese government unveiled the factory to the media amid rampant coronavirus infections in the country.
Wuhan amid COVID surge

Wuhan amid COVID surge

A commercial district in Wuhan is crowded with people wearing masks on Dec. 28, 2022, amid a surge in COVID-19 cases. The Chinese government eased its strict antivirus measures earlier in the month.
Wuhan amid COVID surge

Wuhan amid COVID surge

Photo taken on Dec. 29, 2022, shows Wuhan's Huanan seafood wholesale market, which has been closed for about three years since the initial outbreak of the novel coronavirus there. The Chinese government eased its strict antivirus measures earlier in the month.
Wuhan amid COVID surge

Wuhan amid COVID surge

Elderly patients lie on emergency department beds at a hospital in Wuhan on Dec. 28, 2022, amid a surge in COVID-19 cases. The Chinese government eased its strict antivirus measures earlier in the month.
Wuhan amid COVID surge

Wuhan amid COVID surge

Photo taken on Dec. 29, 2022, shows Wuhan's Huanan seafood wholesale market, which has been closed for about three years since the initial outbreak of the novel coronavirus there. The Chinese government eased its strict antivirus measures earlier in the month.